Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - December 2012

Tablet Formulation Development - Formulation development in practice (1 day)

05 Dec 2012 - 05 Dec 2012 - London, UK

Bookmark and Share

This optional practical day follows the 2 day course ' Tablet Formulation Development ' which introduces and integrates the key elements of tablet development with the principles of Quality by Design (QbD) with 2 days of theory plus an optional practical day in our development laboratory. It will include experimental, hands-on experience of formulation development using the Gamlen Tablet Press.


The programme for this 1 day practical hands-on course covers:

Formulation development in practice

·    Material characterisation for product development

·    Direct compression

·    Wet granulation

·    Drying

·    Milling

·    Compression

·    Formulation evaluation and final selection

LIMITED TO 10 participants only

Who should attend?
The course is designed for people new to tablet development, and those requiring a refresher in the area. It will also benefit Process Development experts wishing to extend their understanding of why products processes can go wrong, and regulatory and quality personnel who need to understand the development process.

Course speakers:
Dr Michael Gamlen, Pharmaceutical Development Services
Michael is Managing Director of Pharmaceutical Development Services Ltd, a Nottingham (UK) -based technical consultancy. He has over 35 years experience of tablet development. Awarded a First Class Honours degree in Pharmacy, specialising in Pharmaceutical Engineering, he studied for a PhD at Nottingham University. He was Head of Tablet Development at the The Wellcome Foundation for 15 years, and has since worked for Vanguard Medica Ltd and as a consultant. He specialises in managing product development, formulation, tablet and process development studies. He has been teaching professional tabletting courses for many years and his courses are highly rated, exceeding the expectation of the participants in many cases.
Michael continually updates the content of his courses with the latest guidance and extracts of up-to-the minute scientific papers.

Dr Dipankar Dey, PharmaTraining Ltd
Dipankar Dey recently joined PharmaTraining Ltd as Training Manager. A graduate of Oxford University and with a PhD from Birmingham University, he was until recently Head of Process and Validation at OYSTAR Manesty, a well known tablet equipment manufacturer. Dipankar has experience in both sterile and solid dose pharmaceuticals, particularly in tablet coating and compression and is interested in PAT techniques to extract useful online information.

Further information
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos